findmyKOL
Clinical trialNCT06616155RecruitingPhase 1/PHASE2Interventional

Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

SponsorUniversity of Michigan Rogel Cancer CenterEnrollment20Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Rush University

    Chicago, Illinois, United States

    Thomas Westbrook
    Not, yet, recruiting
  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michigan, United States

    Zachery R. Reichert
    Recruiting
  • Karmanos Cancer Institute

    Detroit, Michigan, United States

    Frank Cackowski
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2026
Primary completion
30 Jun 2028
Completion
30 Jun 2030
Last update posted
5 May 2026
Registered enrollment
20
Registry id
NCT06616155
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.